EQUUS Total Return
EQS · NYSE
About EQS
- Employees
- 0
- Headquarters
- Houston, Texas
- Listed
- Sep 11, 1992
- Sector
- Financials
- Industry
- Capital Markets
- Website
- equuscap.com
EQS key statistics
- Market cap
- 16.20M
- Price-earnings ratio
- 0.00
- Dividend yield
- 2650.19%
- Average volume
- 11.73K
- Volume
- 770
- Open price
- $0.9075
- High today
- $0.9075
- Low today
- $0.9003
- 52 Week high
- $2.07
- 52 Week low
- $0.765
EQUUS Total Return (EQS) at a glance
EQUUS Total Return (EQS) last traded at $0.9003, with a market cap of 16.20M, a price-to-earnings ratio of 0.00 and a dividend yield of 2650.19%.
Today the stock has traded between $0.9003 and $0.9075. The current price is 0.0% above the day's low and 0.8% below its high.
Volume so far is 770 shares, below the average of 11.73K shares a day.
Over the past year EQUUS Total Return has ranged from $0.765 to $2.07, and now sits 10% of the way up that range.
Similar companies
Companies in the same industry as EQUUS Total Return
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.